COSMO Pharmaceuticals SA Cash Flow-to-Debt Ratio
COSMO Pharmaceuticals SA cash flow-to-debt ratio. COSMO Pharmaceuticals SA (0RGI) has a Cash Flow-to-Debt Ratio of -0.06x as of June 2026, meaning its operating cash flow of £-7.38 Million could theoretically repay 0% of its total liabilities (£121.91 Million) in one year. Check COSMO Pharmaceuticals SA (0RGI) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of COSMO Pharmaceuticals SA (2004–2025)
Cash flow-to-debt ratio of COSMO Pharmaceuticals SA from 2004 to 2025. Historical debt coverage capacity for COSMO Pharmaceuticals SA across 22 annual periods. Check total reinvestment intensity of COSMO Pharmaceuticals SA to assess the company's total reinvestment commitment from operating cash flow.
COSMO Pharmaceuticals SA Cash Flow-to-Debt Ratio by Year (2004–2025)
COSMO Pharmaceuticals SA cash flow-to-debt ratio by year from 2004 to 2025. Year-by-year debt coverage analysis for COSMO Pharmaceuticals SA. For the full cash flow conversion analysis, see COSMO Pharmaceuticals SA (0RGI) cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (GBP) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.09x | £-11.62 Million | £123.36 Million | ▼ -108.2% |
| 2024 | 1.15x | £162.41 Million | £141.68 Million | ▲ +326.0% |
| 2023 | 0.27x | £33.62 Million | £124.94 Million | ▲ +142.0% |
| 2022 | 0.11x | £32.89 Million | £295.80 Million | ▲ +158.3% |
| 2021 | 0.04x | £12.61 Million | £292.88 Million | ▼ -35.0% |
| 2020 | 0.07x | £12.98 Million | £196.04 Million | ▲ +167.3% |
| 2019 | -0.10x | £-18.85 Million | £191.43 Million | ▼ -75.2% |
| 2018 | -0.06x | £-10.16 Million | £180.83 Million | ▲ +83.4% |
| 2017 | -0.34x | £-9.43 Million | £27.86 Million | ▼ -143.6% |
| 2016 | 0.78x | £21.69 Million | £27.92 Million | ▲ +167.9% |
| 2015 | -1.14x | £-39.26 Million | £34.30 Million | ▼ -226.3% |
| 2014 | 0.91x | £66.45 Million | £73.33 Million | ▲ +155.2% |
| 2013 | 0.36x | £8.11 Million | £22.85 Million | ▼ -57.9% |
| 2012 | 0.84x | £27.76 Million | £32.89 Million | ▲ +9.2% |
| 2011 | 0.77x | £11.29 Million | £14.60 Million | ▲ +232.2% |
| 2010 | 0.23x | £7.79 Million | £33.46 Million | ▼ -29.9% |
| 2009 | 0.33x | £3.88 Million | £11.67 Million | ▲ +138.6% |
| 2008 | -0.86x | £-12.52 Million | £14.53 Million | ▼ -312.9% |
| 2007 | -0.21x | £-2.52 Million | £12.08 Million | ▼ -162.7% |
| 2006 | 0.33x | £6.08 Million | £18.27 Million | ▲ +439.9% |
| 2005 | 0.06x | £1.70 Million | £27.58 Million | ▲ +474.9% |
| 2004 | 0.01x | £261.00K | £24.34 Million | — |